BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17952586)

  • 1. Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!
    Banoei MM; Houshmand M; Panahi MS; Shariati P; Rostami M; Manshadi MD; Majidizadeh T
    Cell Mol Neurobiol; 2007 Nov; 27(7):867-75. PubMed ID: 17952586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington's disease.
    Napoli E; Wong S; Hung C; Ross-Inta C; Bomdica P; Giulivi C
    Hum Mol Genet; 2013 Mar; 22(5):989-1004. PubMed ID: 23197653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
    Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
    Lloret A; Dragileva E; Teed A; Espinola J; Fossale E; Gillis T; Lopez E; Myers RH; MacDonald ME; Wheeler VC
    Hum Mol Genet; 2006 Jun; 15(12):2015-24. PubMed ID: 16687439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
    Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
    J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.
    Ma M; Yang Y; Shang H; Su D; Zhang H; Ma Y; Liu Y; Tao D; Zhang S
    J Neurol Sci; 2010 Nov; 298(1-2):57-60. PubMed ID: 20864123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
    Wang H; Lim PJ; Karbowski M; Monteiro MJ
    Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations.
    Neueder A; Kojer K; Gu Z; Wang Y; Hering T; Tabrizi S; Taanman JW; Orth M
    Brain; 2024 Jun; 147(6):2009-2022. PubMed ID: 38195181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
    Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
    J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage.
    Möncke-Buchner E; Reich S; Mücke M; Reuter M; Messer W; Wanker EE; Krüger DH
    Nucleic Acids Res; 2002 Aug; 30(16):e83. PubMed ID: 12177311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the association of genotype and phenotype features of the pathogenesis of Huntington's chorea].
    Hryshchenko NV; Kucherenko AM; Patskun EI; Livshyts' LA
    Tsitol Genet; 2009; 43(3):42-7. PubMed ID: 19938636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlates of mitochondrial function in Huntington's disease muscle.
    Turner C; Cooper JM; Schapira AH
    Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease?
    Oosterloo M; Van Belzen MJ; Bijlsma EK; Roos RA
    J Huntingtons Dis; 2015; 4(2):141-8. PubMed ID: 26397895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntington's disease: how intermediate are intermediate repeat lengths?
    Squitieri F; Jankovic J
    Mov Disord; 2012 Dec; 27(14):1714-7. PubMed ID: 23008174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India.
    Pramanik S; Basu P; Gangopadhaya PK; Sinha KK; Jha DK; Sinha S; Das SK; Maity BK; Mukherjee SC; Roychoudhuri S; Majumder PP; Bhattacharyya NP
    Eur J Hum Genet; 2000 Sep; 8(9):678-82. PubMed ID: 10980573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and neuropathology of Huntington's disease.
    Reiner A; Dragatsis I; Dietrich P
    Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial structural and functional dynamics in Huntington's disease.
    Reddy PH; Mao P; Manczak M
    Brain Res Rev; 2009 Jun; 61(1):33-48. PubMed ID: 19394359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.